149 related articles for article (PubMed ID: 35229187)
1. Spindle cell/sclerosing rhabdomyosarcoma with DCTN1::ALK fusion: broadening the molecular spectrum with potential therapeutic implications.
Fung CK; Chow C; Chan WK; Choi EWK; To KF; Chan JKC; Cheuk W
Virchows Arch; 2022 Apr; 480(4):927-932. PubMed ID: 35229187
[TBL] [Abstract][Full Text] [Related]
2. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
Rekhi B; Dodd L; Dharavath B; Dutt A
Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
[TBL] [Abstract][Full Text] [Related]
3. Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck.
Agaimy A; Dermawan JK; Leong I; Stoehr R; Swanson D; Weinreb I; Zhang L; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2022 Dec; 61(12):701-709. PubMed ID: 35766997
[TBL] [Abstract][Full Text] [Related]
4. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
5. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
Hornick JL; Nielsen GP
Am J Surg Pathol; 2019 Oct; 43(10):1323-1330. PubMed ID: 31107719
[TBL] [Abstract][Full Text] [Related]
6. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
Rekhi B; Upadhyay P; Ramteke MP; Dutt A
Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
[TBL] [Abstract][Full Text] [Related]
7. Rhabdomyosarcoma With
Ishiyama T; Kato I; Ito J; Matsumura M; Saito K; Kawabata Y; Kato S; Takeyama M; Fujii S
Int J Surg Pathol; 2023 Aug; 31(5):805-812. PubMed ID: 36437645
[TBL] [Abstract][Full Text] [Related]
8. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.
Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY
Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891
[TBL] [Abstract][Full Text] [Related]
9. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
[TBL] [Abstract][Full Text] [Related]
10. ZFP64::NCOA3 gene fusion defines a novel subset of spindle cell rhabdomyosarcoma.
Han R; Dermawan JK; Demicco EG; Ferguson PC; Griffin AM; Swanson D; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2022 Nov; 61(11):645-652. PubMed ID: 35521817
[TBL] [Abstract][Full Text] [Related]
11. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
Rekhi B; Singhvi T
APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
[TBL] [Abstract][Full Text] [Related]
12. Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis.
Li Y; Li D; Wang J; Tang J
Diagn Pathol; 2023 Mar; 18(1):41. PubMed ID: 36998041
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
[TBL] [Abstract][Full Text] [Related]
14. Pediatric spindle cell/sclerosing rhabdomyosarcoma with
Fang Z; Duan C; Wang S; Fu L; Yang P; Yu T; Deel MD; Lau LMS; Ma X; Ni X; Su Y
Transl Pediatr; 2024 Jan; 13(1):178-191. PubMed ID: 38323177
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyosarcoma With
Zhong P; Wei S; Xiao H; Zeng Y
Int J Surg Pathol; 2024 Jun; 32(4):758-766. PubMed ID: 37545350
[TBL] [Abstract][Full Text] [Related]
16. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.
Agaram NP; LaQuaglia MP; Alaggio R; Zhang L; Fujisawa Y; Ladanyi M; Wexler LH; Antonescu CR
Mod Pathol; 2019 Jan; 32(1):27-36. PubMed ID: 30181563
[TBL] [Abstract][Full Text] [Related]
17. Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.
Mosquera JM; Sboner A; Zhang L; Kitabayashi N; Chen CL; Sung YS; Wexler LH; LaQuaglia MP; Edelman M; Sreekantaiah C; Rubin MA; Antonescu CR
Genes Chromosomes Cancer; 2013 Jun; 52(6):538-50. PubMed ID: 23463663
[TBL] [Abstract][Full Text] [Related]
18. A novel case of cutaneous myxoid spindle cell neoplasm with FMR1-ALK gene fusion and CD34/S100 co-expression.
Kasago I; Aypar U; Sukhadia P; Vanderbilt C; Ladanyi M; Hurd T; Pulitzer M
J Cutan Pathol; 2023 Jun; 50(6):505-510. PubMed ID: 36325885
[TBL] [Abstract][Full Text] [Related]
19. [Spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological study of 20 cases].
Yang L; Zhang HJ; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):336-342. PubMed ID: 32268670
[No Abstract] [Full Text] [Related]
20. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis].
Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
